Research ArticleClinical Studies

Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series

HIROSHI AOKI, NAOKI MATSUMOTO, HIROSHI TAKAHASHI, MASAYUKI HONDA, TOMOHIRO KANEKO, SHUHEI ARIMA, TOMOTAKA ISHII, TAKU MIZUTANI, RYOTA MASUZAKI, KAZUSHIGE NIREI, HIROAKI YAMAGAMI, MASAHIRO OGAWA, TATSUO KANDA, MITSUHIKO MORIYAMA and KATSUHIRO MIURA
Anticancer Research December 2021, 41 (12) 6225-6230; DOI: https://doi.org/10.21873/anticanres.15442

Article Information

vol. 41 no. 12 6225-6230
DOI 
https://doi.org/10.21873/anticanres.15442
PubMed 
34848477
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 8, 2021
  • Revision received October 19, 2021
  • Accepted October 20, 2021
  • Published online November 30, 2021.
Copyright & Usage 
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. HIROSHI AOKI1,
  2. NAOKI MATSUMOTO1⇑,
  3. HIROSHI TAKAHASHI1,
  4. MASAYUKI HONDA1,
  5. TOMOHIRO KANEKO1,
  6. SHUHEI ARIMA1,
  7. TOMOTAKA ISHII1,
  8. TAKU MIZUTANI1,
  9. RYOTA MASUZAKI1,
  10. KAZUSHIGE NIREI1,
  11. HIROAKI YAMAGAMI1,
  12. MASAHIRO OGAWA1,
  13. TATSUO KANDA1,
  14. MITSUHIKO MORIYAMA1 and
  15. KATSUHIRO MIURA2
  1. 1Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan;
  2. 2Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
  1. Correspondence to: Naoki Matsumoto, Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. Tel: +81 339728111, Fax: +81 339720015, e-mail: matsumotosg{at}yahoo.co.jp
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series
HIROSHI AOKI, NAOKI MATSUMOTO, HIROSHI TAKAHASHI, MASAYUKI HONDA, TOMOHIRO KANEKO, SHUHEI ARIMA, TOMOTAKA ISHII, TAKU MIZUTANI, RYOTA MASUZAKI, KAZUSHIGE NIREI, HIROAKI YAMAGAMI, MASAHIRO OGAWA, TATSUO KANDA, MITSUHIKO MORIYAMA, KATSUHIRO MIURA
Anticancer Research Dec 2021, 41 (12) 6225-6230; DOI: 10.21873/anticanres.15442
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords